- Home
- CMPS vs BMRC Comparison
CMPS vs BMRC Comparison
Compare CMPS & BMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- BMRC
- Stock Information
- Founded
- CMPS 2020
- BMRC 1989
- Country
- CMPS United Kingdom
- BMRC United States
- Employees
- CMPS N/A
- BMRC N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- BMRC Major Banks
- Sector
- CMPS Health Care
- BMRC Finance
- Exchange
- CMPS Nasdaq
- BMRC Nasdaq
- Market Cap
- CMPS 280.2M
- BMRC 334.0M
- IPO Year
- CMPS 2020
- BMRC N/A
- Fundamental
- Price
- CMPS $3.64
- BMRC $23.70
- Analyst Decision
- CMPS Strong Buy
- BMRC Strong Buy
- Analyst Count
- CMPS 6
- BMRC 3
- Target Price
- CMPS $33.60
- BMRC $28.00
- AVG Volume (30 Days)
- CMPS 1.1M
- BMRC 54.3K
- Earning Date
- CMPS 02-27-2025
- BMRC 01-27-2025
- Dividend Yield
- CMPS N/A
- BMRC 4.21%
- EPS Growth
- CMPS N/A
- BMRC N/A
- EPS
- CMPS N/A
- BMRC N/A
- Revenue
- CMPS N/A
- BMRC $59,368,000.00
- Revenue This Year
- CMPS N/A
- BMRC N/A
- Revenue Next Year
- CMPS N/A
- BMRC $13.55
- P/E Ratio
- CMPS N/A
- BMRC N/A
- Revenue Growth
- CMPS N/A
- BMRC N/A
- 52 Week Low
- CMPS $3.17
- BMRC $14.11
- 52 Week High
- CMPS $12.75
- BMRC $27.11
- Technical
- Relative Strength Index (RSI)
- CMPS 42.17
- BMRC 50.49
- Support Level
- CMPS $3.29
- BMRC $23.10
- Resistance Level
- CMPS $3.62
- BMRC $24.00
- Average True Range (ATR)
- CMPS 0.41
- BMRC 0.79
- MACD
- CMPS -0.03
- BMRC 0.07
- Stochastic Oscillator
- CMPS 23.11
- BMRC 66.79
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties, and others. The majority of its revenue comes from interest income.